Tissue banks : the dangers of tainted tissues and the need for federal regulation : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, first session, May 14, 2003.
- United States. Congress. Senate. Committee on Governmental Affairs
- Date:
- 2003
Licence: Public Domain Mark
Credit: Tissue banks : the dangers of tainted tissues and the need for federal regulation : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, first session, May 14, 2003. Source: Wellcome Collection.
58/126 page 54
![and adhere to the standards of CDC’s National Electronic Disease Surveillance System. Conclusion Addressing the problem of infections associated with blood, tissue and organ receipt is part of the larger problem of patient safety, requiring significant changes thraughout all parts of the healthcare industry. Organizations involved in organ and tissue procurement, and suppliers and processors of tissues must put in place assiduously followed procedures to assure that any risks associated with tissue transplantations are greatly minimized if not eliminated. State and federal public health authorities must continue to enhance their ability to collect, analyze, interpret, and disseminate information about potential patient safety hazards due to biological products (including blood, tissue and organs), medical devices, and medical procedures. Clinicians and medical professionals must, with our help, increase their awareness of specific patient safety problems and fulfill their role in reporting such problems promptly to the appropriate authorities so that appropriate action can be taken. CDC, FDA, and other partners, as noted earlier, are actively engaged in ensuring that biological products, including tissue allografts, are as safe as possible. The recent report by the Institute of Medicine (1OM) entitled, Microbial Threats to Heaith: Emergence, Detection, and Response recognized thirteen individual factors contributing to the emergence of microbial threats. These investigations highlight one of these factors identified by the IOM, “the role of advances in medical technologies, such as blood transfusion and organ transplants, [that] have created new pathways for the spread of certain infections.” Thank you very much for your attention. | will be happy to answer any questions you may have. CDC Response Infections Related to Human Tissue Transplantation May 14, 2003](https://iiif.wellcomecollection.org/image/b32221514_0058.jp2/full/800%2C/0/default.jpg)
